Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
ZUG, Switzerland, Dec. 19, 2014 /CNW/ - Licence extension in the contract between AmVac and the Helmholtz Centre for the adjuvant Malp-2 offers sustainable potential for patients, attending...
ZUG, Switzerland, June 17, 2014 /CNW/ - Swiss-based AmVac AG, a private biotech company focused on the development of innovative vaccines, announced today the initiation of a Phase III study with...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.